DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $80,970,000 | -3.4% | 560,617 | -4.4% | 0.77% | -5.1% |
| Q2 2019 | $83,832,000 | +3.3% | 586,564 | -4.5% | 0.81% | +0.9% |
| Q1 2019 | $81,128,000 | +20.0% | 614,510 | -6.2% | 0.80% | +9.4% |
| Q4 2018 | $67,589,000 | -5.1% | 655,444 | +0.0% | 0.73% | +14.2% |
| Q3 2018 | $71,195,000 | +10.2% | 655,207 | +0.0% | 0.64% | +6.6% |
| Q2 2018 | $64,632,000 | -0.0% | 654,965 | -0.8% | 0.60% | -1.1% |
| Q1 2018 | $64,650,000 | +5.1% | 660,301 | -0.3% | 0.61% | +9.3% |
| Q4 2017 | $61,500,000 | +7.5% | 662,569 | -0.6% | 0.56% | +3.5% |
| Q3 2017 | $57,185,000 | +17441.4% | 666,650 | +17148.4% | 0.54% | +17833.3% |
| Q2 2017 | $326,000 | +39.3% | 3,865 | +41.3% | 0.00% | +50.0% |
| Q1 2017 | $234,000 | +13.6% | 2,735 | +3.5% | 0.00% | 0.0% |
| Q4 2016 | $206,000 | -3.7% | 2,642 | -3.1% | 0.00% | 0.0% |
| Q3 2016 | $214,000 | -50.1% | 2,726 | -35.8% | 0.00% | -50.0% |
| Q2 2016 | $429,000 | +100.5% | 4,249 | +88.3% | 0.00% | +100.0% |
| Q1 2016 | $214,000 | -41.0% | 2,256 | -42.2% | 0.00% | -33.3% |
| Q4 2015 | $363,000 | +81.5% | 3,905 | +66.3% | 0.00% | +50.0% |
| Q3 2015 | $200,000 | -55.6% | 2,348 | -55.3% | 0.00% | -50.0% |
| Q2 2015 | $450,000 | -80.7% | 5,254 | -80.9% | 0.00% | -81.0% |
| Q1 2015 | $2,332,000 | +312.0% | 27,465 | +315.8% | 0.02% | +320.0% |
| Q4 2014 | $566,000 | +9.1% | 6,605 | -3.3% | 0.01% | -16.7% |
| Q3 2014 | $519,000 | +10.7% | 6,829 | +14.6% | 0.01% | +50.0% |
| Q2 2014 | $469,000 | +7.6% | 5,959 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $436,000 | +1.4% | 5,816 | +4.5% | 0.00% | 0.0% |
| Q4 2013 | $430,000 | +11.7% | 5,568 | +0.4% | 0.00% | -20.0% |
| Q3 2013 | $385,000 | +23.0% | 5,547 | +12.1% | 0.01% | +25.0% |
| Q2 2013 | $313,000 | +42.3% | 4,949 | +39.6% | 0.00% | +33.3% |
| Q1 2013 | $220,000 | – | 3,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |